000			01255 a2200385 4500
005			20250514011513.0
264		0	_c20011004
008			200110s 0 0 eng d
022			_a0028-4793
040			_aNLM _beng _cNLM
100	1		_aRudlowski, C
245	0	0	_aTrastuzumab and breast cancer. _h[electronic resource]
260			_bThe New England journal of medicine _cSep 2001
300			_a997-8 p. _bdigital
500			_aPublication Type: Case Reports; Letter
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBone Neoplasms _xdrug therapy
650	0	4	_aBreast Neoplasms, Male _xdrug therapy
650	0	4	_aDiphosphonates _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPaclitaxel _xtherapeutic use
650	0	4	_aPamidronate
650	0	4	_aReceptor, ErbB-2 _xanalysis
650	0	4	_aTrastuzumab
700	1		_aRath, W
700	1		_aBecker, A J
700	1		_aWiestler, O D
700	1		_aButtner, R
773	0		_tThe New England journal of medicine _gvol. 345 _gno. 13 _gp. 997-8
999			_c11496985 _d11496985